vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($349.4M vs $207.8M, roughly 1.7× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 7.0%, a 50.4% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $28.6M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
IDYA vs TILE — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $349.4M |
| Net Profit | $119.2M | $24.4M |
| Gross Margin | — | 38.6% |
| Operating Margin | 52.2% | 10.1% |
| Net Margin | 57.4% | 7.0% |
| Revenue YoY | — | 4.3% |
| Net Profit YoY | 330.1% | 12.1% |
| EPS (diluted) | $1.33 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $349.4M | ||
| Q3 25 | $207.8M | $364.5M | ||
| Q2 25 | — | $375.5M | ||
| Q1 25 | — | $297.4M | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | $0 | $344.3M | ||
| Q2 24 | $0 | $346.6M | ||
| Q1 24 | $0 | $289.7M |
| Q4 25 | — | $24.4M | ||
| Q3 25 | $119.2M | $46.1M | ||
| Q2 25 | — | $32.6M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $21.8M | ||
| Q3 24 | $-51.8M | $28.4M | ||
| Q2 24 | $-52.8M | $22.6M | ||
| Q1 24 | $-39.6M | $14.2M |
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 38.1% |
| Q4 25 | — | 10.1% | ||
| Q3 25 | 52.2% | 14.6% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 8.8% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 8.4% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | 57.4% | 12.7% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | $0.41 | ||
| Q3 25 | $1.33 | $0.78 | ||
| Q2 25 | — | $0.55 | ||
| Q1 25 | — | $0.22 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | $-0.60 | $0.48 | ||
| Q2 24 | $-0.68 | $0.38 | ||
| Q1 24 | $-0.53 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $71.3M |
| Total DebtLower is stronger | — | $181.6M |
| Stockholders' EquityBook value | $1.1B | $640.7M |
| Total Assets | $1.2B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $71.3M | ||
| Q3 25 | $786.9M | $187.4M | ||
| Q2 25 | — | $121.7M | ||
| Q1 25 | — | $97.8M | ||
| Q4 24 | — | $99.2M | ||
| Q3 24 | $920.0M | $115.6M | ||
| Q2 24 | $701.7M | $94.2M | ||
| Q1 24 | $698.8M | $89.8M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $307.8M | ||
| Q2 25 | — | $304.4M | ||
| Q1 25 | — | $302.9M | ||
| Q4 24 | — | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | — | $391.8M |
| Q4 25 | — | $640.7M | ||
| Q3 25 | $1.1B | $621.0M | ||
| Q2 25 | — | $575.0M | ||
| Q1 25 | — | $513.1M | ||
| Q4 24 | — | $489.1M | ||
| Q3 24 | $1.2B | $501.6M | ||
| Q2 24 | $931.7M | $451.2M | ||
| Q1 24 | $935.3M | $428.5M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $973.7M | $1.2B | ||
| Q1 24 | $961.5M | $1.2B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $49.3M |
| Free Cash FlowOCF − Capex | $142.2M | $28.6M |
| FCF MarginFCF / Revenue | 68.4% | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 5.9% |
| Cash ConversionOCF / Net Profit | 1.19× | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $49.3M | ||
| Q3 25 | $142.2M | $76.7M | ||
| Q2 25 | — | $30.1M | ||
| Q1 25 | — | $11.7M | ||
| Q4 24 | — | $38.0M | ||
| Q3 24 | $-49.2M | $76.2M | ||
| Q2 24 | $-32.9M | $21.5M | ||
| Q1 24 | $-43.8M | $12.6M |
| Q4 25 | — | $28.6M | ||
| Q3 25 | $142.2M | $66.1M | ||
| Q2 25 | — | $22.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $24.4M | ||
| Q3 24 | $-49.7M | $69.7M | ||
| Q2 24 | $-33.9M | $12.0M | ||
| Q1 24 | $-45.1M | $8.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | 68.4% | 18.1% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | 2.02× | ||
| Q3 25 | 1.19× | 1.66× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | — | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
